LIFE SCIENCE AND PHARMA
Governance at the Speed of Discovery, with the Rigour of Regulation
Life sciences organizations operate at the intersection of scientific innovation and some of the most demanding regulatory frameworks in existence. Clinical trial data, real-world evidence, genomic datasets, and drug safety reporting all carry governance requirements that go beyond standard data management — and the consequences of getting it wrong extend from FDA warning letters to compromised patient outcomes.
AI is accelerating drug discovery, pharmacovigilance, and clinical operations. But model outputs in regulated life sciences environments need audit trails, validation documentation, and governance structures that can withstand regulatory scrutiny. We help organizations build for both.
What we bring to life sciences and pharma:
Data governance specialists with experience in clinical data management, regulatory submissions, and GxP-compliant environments
Advisory support for AI readiness in drug discovery, safety signal detection, and real-world evidence platforms
Governance framework design aligned to FDA 21 CFR Part 11, ICH E6, and emerging AI-in-clinical-trials guidance
Staffing across both permanent data leadership roles and project-based delivery for clinical transformation programs
